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Abstract
Background: Outcome data on two-stage revision surgery for deep infection after septic hip arthritis are limited
and inconsistent. This study presents the medium-term results of a new, standardized two-stage arthroplasty with
preformed hip spacers and cementless implants in a consecutive series of adult patients with septic arthritis of the
hip treated according to a same protocol.
Methods: Nineteen patients (20 hips) were enrolled in this prospective, non-randomized cohort study between
2000 and 2008. The first stage comprised femoral head resection, debridement, and insertion of a preformed,
commercially available, antibiotic-loaded cement hip spacer. After eradication of infection, a cementless total hip
arthroplasty was implanted in the second stage. Patients were assessed for infection recurrence, pain (visual analog
scale [VAS]) and hip joint function (Harris Hip score).
Results: The mean time between first diagnosis of infection and revision surgery was 5.8 ± 9.0 months; the
average duration of follow up was 56.6 (range, 24 - 104) months; all 20 hips were successfully converted to
prosthesis an average 22 ± 5.1 weeks after spacer implantation. Reinfection after total hip joint replacement
occurred in 1 patient. The mean VAS pain score improved from 48 (range, 35 - 84) pre-operatively to 18 (range, 0 -
38) prior to spacer removal and to 8 (range, 0 - 15) at the last follow-up assessment after prosthesis implantation.
The average Harris Hip score improved from 27.5 before surgery to 61.8 between the two stages to 92.3 at the
final follow-up assessment.
Conclusions: Satisfactory outcomes can be obtained with two-stage revision hip arthroplasty using preformed
spacers and cementless implants for prosthetic hip joint infections of various etiologies.
Background
Primary septic arthritis in adults is a rare, but potentially
devastating disease. The key factor in the selection of
the type of surgery is symptom duration. Early onset of
infection can be treated with radical open or arthro-
scopic debridement. Failure rates after debridement
increase rapidly in the first days after onset of symptoms
[1] and more radical surgery may be required as joint
damage takes place. Resection hip arthroplasty helps to
eradicate the infection but leaves the patient with a leg
length discrepancy, dependency on ambulatory aids, and
variable pain relief [2,3].
Two-stage revision with the use of an antibiotic-
loaded acrylic cement spacer is a well-established proce-
dure in the management of chronically infected total hip
replacement [4-6]. Two-stage total hip arthroplasty
(THA) with an interval antibiotic-loaded polymethylme-
tacrylate spacer has been recently proposed to clear
infection and improve hip function after septic hip
arthritis [7-9]. In a recent case report, Regis et al. [10]
described successful two-stage hip reconstruction after
* Correspondence: carlo.romano@grupposandonato.it
† Contributed equally
1Dipartimento di Chirurgia Ricostruttiva e delle Infezioni Osteo-articolari
Istituto Ortopedico I.R.C.C.S. Galeazzi - Via Riccardo Galeazzi, 4 - 20161 -
Milano - Italy
Full list of author information is available at the end of the article
Romanò et al. BMC Infectious Diseases 2011, 11:129
http://www.biomedcentral.com/1471-2334/11/129
© 2011 Romanò et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
septic arthritis with a commercially produced, pre-
formed antibiotic-impregnated cement spacer.
The aim of this prospective, non-randomized cohort
study was to assess the medium-term results in a conse-
cutive series of patients with septic hip arthritis treated
according to the same protocol that involved preformed,
commercially available antibiotic-loaded cement spacers
and cementless implants for two-stage reconstruction of
the hip.
Methods
The cohort consisted of 19 consecutive patients (total of
20 hips as both hips in 1 patient [FF in Table 1] were
treated 2 years apart) referred to our departments from
2000 to 2008 for chronic deep hip joint infection. All
patients had received one or more unsuccessful courses
of systemic antibiotic therapy prior to coming to our
observation. The indications for two-stage revision were:
failure of conservative treatments; clinical and laboratory
signs of persistent inflammation; functional impairment
of the affected joint; and radiographic signs of joint
damage (joint-line narrowing, subchondral osteolysis,
bone loss and/or femoral head necrosis).
All patients provided written consent to participate in
the study and permission to publish clinical images. The
ethics committee of Local Health Authority 1, Milan,
Italy approved the study protocol.
Infection was diagnosed according to the criteria set
forth by Spangehl et al.: at least three positive results for
erythrocyte sedimentation, C-reactive protein, aspiration,
frozen section or intraoperative cultures [11].
Clinical, laboratory and radiographic assessments were
performed by an independent observer pre-operatively
at the time of spacer removal, and at the last follow-up
after reimplantation. Epidemiological data were gathered
using a standard data collection form.
Clinical assessment was performed using a visual ana-
log scale (VAS) (a 100-mm scale where 0 indicates no
pain and 100 maximum tolerable pain) and the Harris
Hip score [12]. Clinical signs of recurrent infection (red-
ness, swelling, pain, fistulae) were recorded at follow-up.
Laboratory tests included complete blood count with
differential, erythrocyte sedimentation rate, C-reactive
protein, urea and creatinine, and creatinine clearance
test.
Plain radiographs were obtained in anteroposterior
and translateral views of the hip joint. Radiographic
examination was performed pre-operatively, at spacer
removal, at reimplantation, at 3, 6 and 12 months post-
operatively, and then yearly thereafter.
The primary outcomes were the rates of infection
recurrence, re-revision for infection and aseptic prosthe-
sis loosening, and clinical outcome at the last follow-up
after revision. The secondary outcomes were eradication
rate of infection, spacer integrity and stability, and clini-
cal outcome at the time of spacer removal.
The surgical procedure was similar in all patients in
this series. All were operated by one of us (CLR or EM)
Table 1 Pre-operative patient characteristics
Patient Sex Etiology of infection Age (yrs) Habits and co-morbidities Isolated microorganism
MZ M Post-osteosynthesis 42 Smoking - Drug abuse MSSA
GS M Post-osteosynthesis 56 Smoking - Alcohol abuse MRSA
MC F Post-osteosynthesis 30 / MRSA
FS F Hematogenous 61 Diabetes MSSA
MB F Intra-articular injection 63 / MSSA
AP M Post-osteosynthesis 46 Smoking - Diabetes Enterococcus
MO M Post-osteosynthesis 66 Smoking MRSA
FF F Hematogenous (bilateral) 52 Radiotherapy - Lymphedema MSSA
GB F Post-osteosynthesis 75 Diabetes Neg
PI F Hematogenous 61 Smoking - Diabets MSSA
GF M Hematogenous 32 Smoking - Diabetes CoNS
CC M Hematogenous 64 Vasculopathy Neg
MR M Post-osteosynthesis 47 / Neg
TS M Post-osteosynthesis 61 / MRSA
LL F Post-osteosynthesis 39 Diabetes Pseudomonas aeruginosa
GR F Hematogenous 66 Rheumatoid arthritis MSSA
DA M Post-osteosynthesis 66 / CoNS
GL F Hematogenous 55 Lymphoma Neg
PQ F Post-osteosynthesis 77 Diabetes CoNS
Abbreviations: MSSA: methicillin-sensitive Staphyloccus aureus; MRSA: methicillin-resistant Staphyloccus aureus; CoNS: coagulase-negative staphylococci; Neg:
negative culture.
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through a lateral approach, with the patient in the
supine position in both the first- and the second-stage
operations.
After radical synovectomy, debridement and excision of
all infected parts, the femoral head was resected onto
healthy bone and the acetabular cavity gently reamed.
Synovial fluid and synovium were obtained for culture.
After debridement, the joint was rinsed with approxi-
mately 10 liters of saline solution. After reaming of the
femoral canal, a preformed antibiotic-loaded hip spacer
(InterSpace® Hip, Tecres SpA, Verona, Italy - Hexactech
Inc. Gainesville, FL, USA) (Figure 1) was implanted. The
InterSpace® Hip is an off-the-shelf polymethylmetacry-
late antibiotic-loaded pre-formed hip spacer. The inner
part of the spacer features a stainless steel rod to enhance
mechanical resistance. The cement is pre-loaded by the
manufacturer with gentamicin (1.9%). The InterSpace®
Hip comes in three different head sizes and two stem
sizes, short (260 mm) and long (360 mm), which may be
intraoperatively chosen on the basis of femoral bone loss
and the need for distal fixation of the implant.
To prevent implant rotation, the spacer was fixed only
in the proximal part with one pack of antibiotic-loaded
cement (Cemex Genta, Tecres) containing gentamicin
(1.9%) and vancomycin (5%). The vancomycin powder
was thoroughly mixed with the cement powder to
obtain a fine consistency before adding the liquid mono-
mer. No bone grafts were used at the time of spacer
implantation. All patients received a minimum of 4
weeks of organism-specific antibiotics postoperatively
and returned for clinical follow-up at the completion of
their antibiotic course.
Patients with successful eradication of infection, as
evidenced clinically and by complete blood count with
differential and C-reactive protein within the normal
range, underwent the second stage of hip joint recon-
struction. In cases of clinical suspicion of persistent
infection, the hip joint was aspirated before reimplanta-
tion and samples were obtained for culture and white
blood cell count. Intraoperative cultures were obtained
at the second stage procedure in all cases. At revision,
the hip was exposed through the same lateral incision
and the spacers were removed.
Revision was performed with modular titanium
cementless femoral components (Profemur, Wright,
AEQUA, AdlerOrtho or S-ROM, Johnson&Johnson
DePuy). Unconstrained cementless acetabular compo-
nents were used in all cases. Partial weight bearing with
two-crutches was allowed for 6 weeks, then one-crutch
walking for 4 to 6 more weeks. Full weight bearing was
permitted at 10 to 12 weeks after surgery. Systemic anti-
biotics were administered for 4 weeks after the opera-
tion. No drains were placed after either procedure.
All patients received enoxaparin 0.4 ml/die for 30 days
after surgery to prevent thromboembolic complications
and celecoxib 200 mg/die for 14 days after revision sur-
gery to prevent heterotopic ossifications [13].
Results
Table 1 reports patient demographics and pre-operative
characteristics. Of the total of 19 patients, 14 (73%)
were identified as type-B hosts, i.e., patients with one or
more risk factors for infection (Table 1), according to
the Cierny-Mader classification [14]. There was a mean
5.8 ± 9.0 months between the diagnosis of infection and
the index-surgery. Four out of 19 (21%) patients
received one surgery (two open and two arthroscopic,
respectively) after diagnosis of infection and prior to
spacer implantation.
In 11 patients, joint aspiration was performed prior to
surgery at our institution; none of these patients pre-
sented with draining fistulas and previous cultures were
either not available or negative.
At least 5 different tissue samples were taken perio-
peratively in all the cases. Cultures were positive in 16
of 20 hips (80%). Staphylococcus aureus and coagulase-
negative staphylococci (CoNS) (13/20) were predomi-
nantly identified (Table 1).
Figure 1 The preformed spacer used in the study. The
preformed spacer comes in two stem lengths and three head sizes
(not shown).
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The duration of postoperative antibiotic treatment
after spacer implantation was from 4 to 6 weeks (mean
5.2 ± 1.1); methicillin-sensitive gram-positive bacteria
were treated with a combination of amoxicillin/clavula-
nic acid or cephalosporins and levofloxacin, or trimetho-
prim/sulfamethoxazole or rifampicin; methicillin-
resistant bacteria were treated with a combination of a
glycopeptide (vancomycin or teicoplanin) with either
levofloxacin or trimethoprim/sulfamethoxazole or rifam-
picin. Patients with negative culture results were treated
empirically with a combination of vancomycin or teico-
planin and levofloxacin; the patient with Pseudomonas
aeruginosa infection was treated with meropenem and
levofloxacin according to the antibiogram.
Joint aspiration was also performed in two patients
with clinical suspicion of persistent infection prior to
spacer removal; the culture tested negative in both cases
and the leukocyte count was 600/uL and 480/uL,
respectively.
All 20 hips were successfully converted to THA an
average 22.3 ± 5.1 weeks after spacer implantation.
Complications included two spacer dislocations, one
transient femoral nerve palsy, and two deep vein throm-
bosis. At the time of spacer removal, a single intraopera-
tive specimen gave a positive culture result in two
patients (coagulase-negative bacteria in both cases),
without pre-operative signs of infection. No alteration in
the routine postoperative protocol as regards antibiotic
treatment duration (4 weeks) was made in either case;
the choice of antibiotics (vancomycin and levofloxacin
in both cases) was decided according to the results of
antibiogram testing of the bacteria isolated from intrao-
perative cultures.
At a mean follow-up of 56.6 months (range, 24 - 104),
none of the patients was lost, but one died four years
after surgery in a road car accident. One patient (AP)
developed recurrence of infection associated with sink-
ing of the femoral stem which required re-revision two
years after intervention. This patient was a heavy smo-
ker with a history of diabetes, post-traumatic hip infec-
tion, associated with osteomyelitis of the proximal third
of the femur, and had presented with draining fistulas
and enterococcus infection.
None of the remaining patients required reinterven-
tion; they showed no local or general signs or laboratory
data of infection and never had to restart antibiotics at
any point.
The average VAS pain score was 48 ± 20 (range, 35 -
84) pre-operatively, 18 ± 15 (range, 0 - 38) prior to
spacer removal, and 8 ± 10 (range, 0 - 15) at the last
follow-up after prosthesis implantation. The mean Har-
ris Hip score was 27.5 ± 15.3 pre-operatively, 61.8 ±
18.6 at the time of spacer removal, and 92.3 ± 17.4 at
the final follow-up assessment.
A leg length discrepancy between 1 and 2 cm was
observed in three patients and less than 1 cm in the
remaining patients.
No hip prosthesis dislocation occurred. No component
showed migration or osteolysis at radiographic evalua-
tion (Figures 2, 3 and 4).
Discussion
Based on the most recent literature, staged reconstruc-
tion of the hip after septic arthritis may be considered
as a reliable alternative to conventional resection arthro-
plasty. However, owing to the limited series and the dif-
ferences in technical approach, the results with this
procedure appear unpredictable and difficult to
standardize.
Chen et al. [15] reported a re-infection rate of 14%
and a complication rate of 36% after two-stage THA
without temporary devices for primary septic arthritis of
the hip. Morshed et al. [16] described a case of post-
injection septic arthritis of the hip successfully managed
with the implantation of an antibiotic-impregnated
cement block and a hip prosthesis after failed previous
surgical debridement and partial femoral head resection.
A more recent case report was published by Barrett and
Bal [17]; very recently, Regis et al. [10] were the first to
report on another single case of hematogenous infection
successfully treated with a preformed hip spacer and a
cementless hip prosthesis.
Apart from these case reports, as far as we know, only
five papers have described a series of patients treated
with a temporary device and a hip prosthesis in the sec-
ond stage for septic hip arthritis. Schoellner et al. [18]
were probably the first to report a preliminary experi-
ence with five individually manufactured bone cement
spacers for septic hip revision. They highlighted the
adaptability of this mechanically tested stem and dis-
cussed its indication in primary joint infection without
giving additional details. The relevant data from the four
other more detailed papers are reported in Table 2 and
compared with those of the present study. The infection
recurrence rate after prosthesis implantation ranges
from 0 to 15%. This latter result was reported by Bauer
Figure 2 Clinical case (patient GF) . Pre-operative X-ray and
intraoperative finding. Hematogenous septic hip arthritis.
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et al. [19], who recently described a retrospective mixed
series of patients treated with either one- or two-stage
procedures after hip or knee septic arthritis. In this
paper, “evolutive septic arthritis” (17 knees and 13 hips)
was treated with a two-stage procedure. The short time
interval between stages (mean, 6 weeks) and the absence
of antibiotic in the cement spacer may explain the rela-
tively high incidence of infection recurrence.
Our results are in line with previously published data
at a longer follow-up and in a larger patient series. Ours
is also the first paper to document, in a prospectively
followed patient cohort, the safety and efficacy of a pre-
formed spacer and cementless hip prosthesis.
The most relevant clinical advantage of using an
antibiotic-loaded spacer is that it helps to maintain
joint space and minimizes the risk of large limb short-
ening, while local antibiotic delivery prevents bacterial
re-colonization of the implant [4-10]. Furthermore,
preformed antibiotic-loaded spacers offer off-the-shelf
availability, a standardized and reproducible technique,
known mechanical resistance [20,21], predictable anti-
biotic release [22] and shorter operating time [23,24],
being available in short and long stemmed shapes [25]
that can be chosen intraoperatively based on femoral
bone loss.
The choice of antibiotics loaded to the cement spacer
and administered systemically in this series was clearly
effective, with proper surgical technique, in eradicating
infection in patients with septic hip arthritis due to differ-
ent bacteria, including methicillin-resistant strains. How-
ever, with the growing occurrence of multi-drug and
vancomycin-resistant strains, the use of more recently
available antibacterial agents may be necessary in selected
cases. The efficacy of daptomycin or linezolid in treating
septic arthritis is currently under study [26,27].
The main limitations of the present study are the lim-
ited sample size, the lack of a comparator group, and
the relatively short duration of follow-up. Due to the
Figure 3 Clinical case (patient GF). Postoperative X-ray prior to
hip spacer removal.
Figure 4 Clinical case (patient GF). Radiographic control four
years after cementless hip prosthesis implantation.
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relatively low prevalence of septic arthritis of the hip,
coordinated multicenter randomized trials are needed to
evaluate long-term outcomes after two-stage revision
with this technique.
Conclusions
Two-stage total hip arthroplasty with preformed hip
spacers and cementless implants provide a reliable solu-
tion in the medium-term follow-up for septic arthritis of
the hip and may be offered to patients as a valuable
treatment option.
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